65 i b, drugs, pharmaceuticals,&hematology related products, FSS contract award

Ended Awarded Last action

Contract number
36F79720D0170
Awardee
Awarding agency
Task orders
3

Award facts

Opportunity
  • M5Q50A08 Solicitation number
Last date to order 100% complete
IDV ceiling
$250,000.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs awarded a Federal Supply Schedule contract to Global Blood Therapeutics, Inc. against the Pharmaceuticals and Drugs schedule (FSS-61-IB) to procure the medication OXBRYTA. Three delivery orders have since been placed by the Department of Justice Bureau of Prisons Federal Correctional Complex Terre Haute against this contract, totaling $177,907 to provide OXBRYTA for inmates at the facility. Performance is carried out by Global Blood Therapeutics in South San Francisco, California through March 2023. No set-asides were applied to the contract or delivery orders. OXBRYTA treats sickle cell disease and supports the healthcare programs at the Bureau of Prisons facility. Global Blood Therapeutics serves as the prime contractor fulfilling delivery of the medication to address the medical needs of inmates as intended through the established GSA supply schedule.

The contract and delivery orders aim to procure the medication OXBRYTA, which treats sickle cell disease, for inmates at the Department of Justice Bureau of Prisons Federal Correctional Complex Terre Haute facility in Indiana. Global Blood Therapeutics performs as the prime contractor supplying OXBRYTA through March 2023 at a total value of $177,907 to meet the healthcare requirements of inmates as overseen by the Bureau of Prisons.

Task orders

Task order Ordering agency Obligated Awarded
Oxbryta medication 15B41823F00000070 Federal Correctional Complex Terre Haute (BOP) $93,571
Oxbryta medication 15B41822F00000189 Federal Correctional Complex Terre Haute (BOP) $62,502
Oxbryta medication 2 month supply 15B41822F00000089 Federal Correctional Complex Terre Haute (BOP) $20,834

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 · Contract cancellation $0
Supplemental Agreement for work within scope P00009 · Product deletions, 42-2A $0
Other Administrative Action P00008 · ADM CHG: POC chgs and revised signatory authority $0
Supplemental Agreement for work within scope P00007 · PL 2023 $0
Supplemental Agreement for work within scope P00006 · Life cycle $0
Supplemental Agreement for work within scope P00005 · Admin $0
Supplemental Agreement for work within scope P00004 · Addition $0
Supplemental Agreement for work within scope P00003 · Public law 2022 $0
Supplemental Agreement for work within scope P00002 · Admin $0
Supplemental Agreement for work within scope P00001 · PL 2021 $0
Original award $0
Show all 11

Quick answers

Who was awarded contract 36F79720D0170?

36F79720D0170 was awarded to Global Blood Therapeutics, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on July 15, 2020.

How much is contract 36F79720D0170 worth?

36F79720D0170's own ceiling is $250,000.

How many orders have been placed under contract 36F79720D0170?

3 orders have been placed under 36F79720D0170, the latest on March 14, 2023.

Who can order from contract 36F79720D0170?

36F79720D0170 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79720D0170 part of a contract vehicle?

Yes. 36F79720D0170 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79720D0170 competed?

The extent of competition for 36F79720D0170 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV